Key facts
- This page summarizes Catherine Cusack's Form 4 filing for Sabra Health Care REIT, Inc. (SBRA).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 02 Dec 2022, 16:11.
Catherine Cusack - 30 Nov 2022 Form 4 Insider Report for Sabra Health Care REIT, Inc. (SBRA)
- Reporting relationship
- Director
- Issuer ticker
- SBRA
- Reported as of
- 30 Nov 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 02 Dec 2022, 16:11:48 UTC
- Prior SEC filing
- 02 Sep 2022
- Next SEC filing
- 02 Mar 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael Costa as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Catherine Cusack filed Form 4 for Sabra Health Care REIT, Inc. (SBRA) on 02 Dec 2022.
Change
- Previous filing in this sequence was filed on 02 Sep 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SBRA
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +449
- Change %
- +1.8%
- Price
- $0.000000
- Shares after
- 24,787
- Date
- 30 Nov 2022
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.
Footnote F2
Includes 5,329 unvested stock units and 14,458 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock.